Heart device data collected from 500 chinese patients

NCT ID NCT04085445

Completed Knowledge-focused Sponsor: Boston Scientific Corporation Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 28 times

Summary

This study gathered real-world information on how well a special balloon catheter (Agent DCB) works for opening blocked heart arteries in Chinese patients. Researchers followed 500 adults for 12 months after their procedure to track heart-related events like heart attacks or the need for repeat procedures. The goal was to understand the device's performance in everyday clinical practice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHINESE PATIENTS TREATED WITH AGENT DCB are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Cheng Hsin General Hospital

Taipei, Taiwan
China Medical University Hospital

Taichung, Taiwan
Hualien Tzu Chi Hospital

Hualien City, 970, Taiwan
Kaohsiung Veterans General Hospital

Kaohsiung City, Taiwan
Mackay Memorial Hospital

Taipei, Taiwan
National Taiwan University Hospital

Taipei, Taiwan
Queen Mary Hospital

Hong Kong, Hong Kong
Taipei Veterans General Hospital

Taipei, Taiwan
Tan Tock Seng Hospital

Singapore, Singapore

Conditions

Explore the condition pages connected to this study.

CHINESE PATIENTS TREATED WITH AGENT DCB CHINESE PATIENTS TREATED WITH AGENT DCB